Swiss All Share Index
17.515,83
PKT
-77,08
PKT
-0,44
%
Werbung
Analysen zu Swiss All Share Index-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 21.04.22 | Nestlé Underperform | Jefferies & Company Inc. | |
| 20.04.22 | DocMorris Sell | UBS AG | |
| 20.04.22 | Swiss Re Overweight | Barclays Capital | |
| 20.04.22 | DocMorris Add | Baader Bank | |
| 20.04.22 | UBS Hold | Jefferies & Company Inc. | |
| 20.04.22 | UBS Sector Perform | RBC Capital Markets | |
| 20.04.22 | DocMorris Buy | Jefferies & Company Inc. | |
| 20.04.22 | UBS Underweight | JP Morgan Chase & Co. | |
| 19.04.22 | Roche Buy | Jefferies & Company Inc. | |
| 19.04.22 | Novartis Buy | Jefferies & Company Inc. | |
| 19.04.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 19.04.22 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 19.04.22 | Nestlé Overweight | JP Morgan Chase & Co. | |
| 19.04.22 | Roche Sell | UBS AG | |
| 19.04.22 | Holcim Equal Weight | Barclays Capital | |
| 14.04.22 | Holcim Outperform | Credit Suisse Group | |
| 14.04.22 | Holcim Neutral | JP Morgan Chase & Co. | |
| 14.04.22 | UBS Hold | Deutsche Bank AG | |
| 14.04.22 | Swiss Re Neutral | JP Morgan Chase & Co. | |
| 14.04.22 | ams-OSRAM Hold | Jefferies & Company Inc. | |
| 13.04.22 | UBS Neutral | UBS AG | |
| 13.04.22 | Givaudan Neutral | UBS AG | |
| 13.04.22 | Givaudan Hold | Deutsche Bank AG | |
| 13.04.22 | Roche Equal-weight | Morgan Stanley | |
| 13.04.22 | Givaudan Neutral | Goldman Sachs Group Inc. | |
| 13.04.22 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
| 13.04.22 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 12.04.22 | DocMorris Sell | UBS AG | |
| 12.04.22 | Givaudan Neutral | Goldman Sachs Group Inc. | |
| 12.04.22 | DocMorris Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 12.04.22 | Givaudan Underweight | Barclays Capital | |
| 12.04.22 | Givaudan Add | Baader Bank | |
| 12.04.22 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 12.04.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 12.04.22 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 12.04.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 12.04.22 | Givaudan Underperform | Jefferies & Company Inc. | |
| 11.04.22 | UBS Underweight | JP Morgan Chase & Co. | |
| 11.04.22 | Richemont Outperform | RBC Capital Markets | |
| 11.04.22 | DocMorris Sell | UBS AG |